3060F Pos microalbuminuria revision
Also known as: microalbuminuria positive documented, early nephropathy documented, urine protein documented
Documentation of positive microalbuminuria result (urinary albumin excretion 30-299 mg/day) in diabetic patient, indicating early diabetic nephropathy.
In Plain Language
protein in urine documented
Clinical Context
Quality measure code identifying patients with early diabetic kidney disease; indicates need for angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy.
RVU Information
CPT 3060F does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Documentation should include the clinical indication, service details, and any applicable performance metrics. Coverage may vary by payer — verify acceptance before billing.
Specialties
Frequently Asked Questions
What is CPT code 3060F?
CPT 3060F (Pos microalbuminuria revision) is a Other code. Documentation of positive microalbuminuria result (urinary albumin excretion 30-299 mg/day) in diabetic patient, indicating early diabetic nephropathy.
Who uses CPT code 3060F?
CPT 3060F is used by Nephrology, Endocrinology, Family Medicine. Quality measure code identifying patients with early diabetic kidney disease; indicates need for angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy.
When is CPT 3060F used?
Quality measure code identifying patients with early diabetic kidney disease; indicates need for angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.